Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

NCT00421421 ·Status: TERMINATED ·Phase: PHASE4

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

NCT00537654 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

NCT00690950 ·Status: UNKNOWN ·Phase: PHASE4

Drug Use Investigation for AVOLVE(BPH)

NCT01376284 ·Status: COMPLETED

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

NCT01254071 ·Status: COMPLETED ·Phase: PHASE1

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement

NCT01294592 ·Status: COMPLETED ·Phase: PHASE4

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

NCT00375765 ·Status: COMPLETED ·Phase: PHASE4

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

NCT00368979 ·Status: COMPLETED ·Phase: PHASE3

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

NCT00274417 ·Status: UNKNOWN ·Phase: NA

Bioequivalence - Duodart Against Avodart & Omnic

NCT01657851 ·Status: COMPLETED ·Phase: PHASE1

Prospective Sexual Function Study for BPH Subjects

NCT01777269 ·Status: COMPLETED ·Phase: PHASE4

A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms

NCT01139762 ·Status: COMPLETED ·Phase: PHASE3

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

NCT00090103 ·Status: COMPLETED ·Phase: PHASE3

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

NCT02052713 ·Status: COMPLETED ·Phase: PHASE1

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)

NCT04831476 ·Status: COMPLETED

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)

NCT00939120 ·Status: COMPLETED ·Phase: PHASE4

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

NCT01471678 ·Status: COMPLETED ·Phase: PHASE1

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

NCT00062790 ·Status: COMPLETED ·Phase: PHASE4

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

NCT00398281 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

NCT00866554 ·Status: COMPLETED ·Phase: PHASE2

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

NCT00985738 ·Status: TERMINATED ·Phase: PHASE2

Safety and Pharmacokinetic Characteristics of DKF-313

NCT02352311 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

NCT04947631 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

NCT01351987 ·Status: UNKNOWN